Inovio Pharma (INO)
$8.33
0.10 (1.19%)
INO Stock Quote Delayed 30 Minutes
Why Inovio Pharmaceuticals May Get a Pass on Coronavirus Vaccine Hype
INO stock has its fair share of critics and under normal circumstances, those criticisms could cripple it. However, these are not normal circumstances.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
1.75B
PE Ratio
-1.15
EPS
-7.24
Volume (Avg. Vol.)
136,535
Day's Range
$8.25 - $8.59
52-Week Range
$0.32 - $14.75
Dividend & Yield
N/A (N/A)
INO Stock Predictions, Articles, and Inovio Pharma News
Is Inovio Pharmaceuticals Really Just the Next Theranos?
Even scientists are still guessing whether any Covid-19 treatment or vaccine works. Inovio's INO-4800 might work, but we won't know for about a year.
Inovio Stock Poised for Growth as Preliminary Research Shows Promise
Vaccine trials are in progress, and although it isn't the only player on the field, Inovio stock has a clear head-start on the competition.
Inovio Stock Demonstrates Worth for Those Who Can Handle Risk
It might be based on Covid-vaccine hope, but INO stock's momentum is undeniable. Here are the facts behind the hype.
Inovio Stock Is Entirely Dependent on Its Coronavirus Vaccine
Nothing else matters with Inovio Pharmaceuticals. Keep a close eye on its vaccine, because that's all that's driving INO stock here.
Add Inovio Stock to Your High-Growth Biotech Holdings
You can call INO a coronavirus stock, but it's really much more than that.
Inovio Shows Plenty of Promise Outside of the Coronavirus
If Inovio Pharmaceuticals' human trial results are as solid as the world hopes, INO stock could quickly race to $20.
Inovio Stock Shows Plenty of Promise Ahead
The clinical results from Inovo's INO-4700 validate the upside potential in INO stock.
Inovio Pharmaceuticals Is Hurting From Remdesivir but It’s Still Standing
With White House health advisor Dr. Anthony Fauci’s endorsement of Gilead Sciences’ remdesivir, INO stock now seems irrelevant. But that might not be accurate if you look at the broader context.
The Fundamentals Say the Time to Buy INO Stock Has Passed
Inovio stock doesn't have the fundamentals to back up its bullish-leaning technicals. Here's what do with INO stock as a result.
Why Investors Should Avoid Inovio Pharmaceuticals
Investors should avoid INO stock and buy MRNA stock instead on weakness because Moderna's credentials are much more impressive at this point.
What Lies Ahead for Vaccine Development and INO Stock in May?
Biotechnology company Inovio currently has no approved products on the market and INO stock's recent run up in price is based on a potential COVID-19 vaccine that may be months or even years away
5 Top Stock Trades for Friday: GILD, INO, LVS, DPZ, LLY
Eli Lilly, Domino's Pizza, Gilead Sciences, Las Vegas Sands and Inovio Pharmaceuticals were our top stock trades for Friday.
Bullish Play on Inovio as it Develops COVID-19 Vaccine
The major indexes continue to rally. Take advantage by using a bullish position on Inovio Pharmaceuticals, Inc. (NASDAQ:INO).
Bet on INO Stock Beyond Its Promising Covid-19 Vaccine Developments
Inovio just launched its Phase 1 trials of INO-4800 for a vaccine. Should all go according to plan, INO could run to at least $20 a share.
INO Stock May Fade After the Virus, but It Could Rocket to $20 First
With phase one of human trials underway, we may be closer than ever to putting the virus to bed. Before that happens, INO stock will run.
Inovio Stock Isn’t A Coronavirus Bet Worth Buying Into
Although Inovio has the potential to explode higher on a coronavirus vaccine, the firm's hefty debt pile and lack of other catalysts makes it too risky to buy right now.
